Centerpoint Advisors, LLC Pfizer Inc Transaction History

Centerpoint Advisors, LLC

$288 Million
Q3 2024

A detailed history of Centerpoint Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 1,652 shares of PFE stock, worth $42,373. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,652

Previous 4,152 60.21%

Holding current value

$42,373

Previous $116,000 58.62%

% of portfolio

0.02%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $69,250 - $78,475	-2,500 Reduced 60.21%	1,652 $48,000
Q2 2024 Jul 30, 2024	SELL	$25.26 - $29.6 $17,303 - $20,276	-685 Reduced 14.16%	4,152 $116,000
Q1 2024 May 02, 2024	BUY	$25.89 - $29.73 $647 - $743	25 Added 0.52%	4,837 $134,000
Q4 2023 Jan 16, 2024	SELL	$26.13 - $33.94 $31,617 - $41,067	-1,210 Reduced 20.09%	4,812 $139,000
Q3 2023 Nov 01, 2023	BUY	$32.09 - $37.51 $12,707 - $14,853	396 Added 7.04%	6,022 $200,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $42,383 - $55,177	1,076 Added 23.65%	5,626 $230,000
Q4 2022 Jan 24, 2023	BUY	$41.75 - $54.5 $28,598 - $37,332	685 Added 17.72%	4,550 $233,000
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $105,024 - $128,208	-2,400 Reduced 38.31%	3,865 $169,000
Q2 2022 Jul 18, 2022	BUY	$46.53 - $55.17 $111,672 - $132,408	2,400 Added 62.1%	6,265 $328,000
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $51,697 - $64,059	-1,130 Reduced 22.62%	3,865 $200,000
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $40,578 - $45,968	1,130 Added 29.24%	4,995 $196,000
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $2,730 - $3,203	86 Added 2.28%	3,865 $142,000
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $4,307 - $5,225	143 Added 3.93%	3,779 $124,000
Q1 2020 Apr 23, 2020	SELL	$27.03 - $38.62 $2,000 - $2,857	-74 Reduced 1.99%	3,636 $119,000
Q4 2019 Jan 14, 2020	BUY	$32.92 - $37.36 $1,646 - $1,868	50 Added 1.37%	3,710 $145,000
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $6,471 - $7,266	-175 Reduced 4.56%	3,660 $159,000
Q1 2019 Apr 25, 2019	BUY	$37.5 - $41.2 $11,587 - $12,730	309 Added 8.76%	3,835 $163,000
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $1,999 - $2,424	58 Added 1.67%	3,526 $155,000
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $223,769 - $238,560	-6,785 Reduced 66.18%	3,468 $126,000
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $7,211 - $8,366	226 Added 2.25%	10,253 $364,000
Q4 2017 Mar 14, 2018	BUY	$33.26 - $35.29 $333,498 - $353,852	10,027	10,027 $363,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.

Account

Centerpoint Advisors, LLC Pfizer Inc Transaction History